KORU Medical Systems, Inc.

KRMD

CIK 0000704440 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$11M
↑+23.3% +$2Mvs FY2024 (Q4)
Gross Profit
$7M
↑+22.6% +$1Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Excellent
81/100
  • Profitability
    0ROIC -13.9% (10% = solid, 20%+ = moat)
  • Liquidity
    97Current Ratio 2.44 (above 1.5 = solid)
  • Leverage
    95D/E 0.10 (under 0.5 = conservative)
  • Efficiency
    99Asset Turnover 1.48x (1.0+ = capital-efficient)
  • Growth
    94Revenue YoY +23.3% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin -8.3% · trend +11.5pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$933K
investment in PP&E
Stock buybacks (TTM)
share count reduction
Stock-based comp (TTM)
$3M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$28M
everything owned
Total liabilities
$11M
everything owed
Stockholders' equity
$17M
shareholder claim
Net debt
$-8M
Net cash position ($8M)

Recent performance · 66 quarters

Revenue↑+23.3% +$2M
$11M
Net Income↑+50.8% +$803K
$-778K
Free Cash Flow↓-26.9% -$253K
$687K
Operating Margin↑+12.5pts
-8.3%

Drill down